title: [Viral vaccines in the national vaccination program--views of the near future].
abstract: Both conventional virus vaccines and those being introduced in the near future are either live attenuated viruses or nonliving inactivated viruses, mere virus-like particles (VLP) or purified proteins. Live vaccines yield a "more natural" immunity, but in many cases also a nonliving vaccine is sufficient to protect from viral infections. Influenza vaccines are of both types. The commencing HPV vaccination program will be conducted with a VLP vaccine comprising two serotypes. A live chickenpox vaccine will be introduced in the national vaccination program in the next few years. In addition, a shingles vaccine is needed. The live oral rotavirus vaccine works well.
authors.affiliation: Tampereen yliopiston rokotetutkimuskeskus.
authors.forename: Timo
authors.initials: T
authors.lastname: Vesikari
mesh_terms: D002644:Chickenpox / Q000276:immunology / Q000517:prevention & control; D005387:Finland; D006562:Herpes Zoster / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control; D009313:National Health Programs; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control; D012400:Rotavirus Infections / Q000276:immunology / Q000517:prevention & control; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D014765:Viral Vaccines